Literature DB >> 32692298

MRI and Quantitative Magnetic Susceptibility Maps of the Brain after Serial Administration of Gadobutrol: A Longitudinal Follow-up Study.

Yangsean Choi1, Jinhee Jang1, Jiwoong Kim1, Yoonho Nam1, Na-Young Shin1, Kook-Jin Ahn1, Sin-Soo Jeon1, Bum-Soo Kim1.   

Abstract

Background The relationship between administration of macrocyclic gadolinium-based contrast agents and T1-weighted signal intensity (SI) change of the globus pallidus (GP) and dentate nucleus (DN) is, to the knowledge of the authors, not known. Purpose To determine if quantitative susceptibility mapping (QSM) can detect changes in magnetic susceptibility of the GP and DN after serial administration of macrocyclic gadobutrol in patients with primary brain tumors. Materials and Methods Patients diagnosed with primary brain tumors from August 2014 to February 2019 were eligible for this single-center retrospective study. Among 501 consecutive adult patients who were given at least one administration of gadobutrol, those who were previously administered an unknown or linear gadolinium-based contrast agent were excluded. Brain MRI scans with three-dimensional gradient-recalled-echo image phase data for QSM processing were reviewed. Regions of interest were drawn on the GP and DN on the basis of semiautomatic thresholding. Univariable generalized estimation equations were used to determine the associations between MRI measures (SI on T1-weighted images and magnetic susceptibility on QSM) and number of gadobutrol doses. Potential confounding factors were adjusted for in multivariable generalized estimating equation. Results Ninety patients (mean age, 51 years ± 17 [standard deviation]; 51 men) with 199 MRI scans were analyzed. In models adjusted for repeated observations between injections, the number of injections of gadobutrol was associated with the magnetic susceptibility of the GP (1.4 × 10-3 ppm/number of gadobutrol injections; P = .01) and DN (8.1 × 10-4 ppm/number of gadobutrol injections; P = .03). After adjustment for confounders, the number of gadobutrol injections remained an independent predictor of increased magnetic susceptibility in the GP (1.3 × 10-3 ppm/number of gadobutrol injections; 95% confidence interval: 0.39 × 10-3, -2.4 × 10-3; P = .006). There were no associations between number of gadobutrol injections and SI or magnetic susceptibility in the DN. Conclusion The magnetic susceptibility of the globus pallidus increased after serial administration of gadobutrol. © RSNA, 2020 Online supplemental material is available for this article. See also the editorial by Wang and Prince in this issue.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32692298     DOI: 10.1148/radiol.2020192579

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  Quantitative Susceptibility Mapping Is Superior to T1-weighted Imaging for Detecting and Measuring Gadolinium.

Authors:  Yi Wang; Martin R Prince
Journal:  Radiology       Date:  2020-07-21       Impact factor: 11.105

2.  Increased Brain Iron Deposition in the Putamen in Patients with Type 2 Diabetes Mellitus Detected by Quantitative Susceptibility Mapping.

Authors:  Jing Li; Qihao Zhang; Nan Zhang; Lingfei Guo
Journal:  J Diabetes Res       Date:  2020-09-25       Impact factor: 4.011

3.  Positron Emission Tomography-Magnetic Resonance Imaging Pharmacokinetics, In Vivo Biodistribution, and Whole-Body Elimination of Mn-PyC3A.

Authors:  Iris Yuwen Zhou; Ian A Ramsay; Ilknur Ay; Pamela Pantazopoulos; Nicholas J Rotile; Alison Wong; Peter Caravan; Eric M Gale
Journal:  Invest Radiol       Date:  2021-04-01       Impact factor: 10.065

Review 4.  [Brain Iron Imaging in Aging and Cognitive Disorders: MRI Approaches].

Authors:  Jinhee Jang; Junghwa Kang; Yoonho Nam
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2022-05-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.